These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 36706864)

  • 1. Gaseous nitric oxide failed to inhibit the replication cycle of SARS-CoV-2 in vitro.
    Rousseaud A; Prot M; Loriere ES; Katz I; Ramirez-Gil JF; Farjot G
    Nitric Oxide; 2023 Mar; 132():27-33. PubMed ID: 36706864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitigation of the replication of SARS-CoV-2 by nitric oxide in vitro.
    Akaberi D; Krambrich J; Ling J; Luni C; Hedenstierna G; Järhult JD; Lennerstrand J; Lundkvist Å
    Redox Biol; 2020 Oct; 37():101734. PubMed ID: 33007504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiviral Activity of Type I, II, and III Interferons Counterbalances ACE2 Inducibility and Restricts SARS-CoV-2.
    Busnadiego I; Fernbach S; Pohl MO; Karakus U; Huber M; Trkola A; Stertz S; Hale BG
    mBio; 2020 Sep; 11(5):. PubMed ID: 32913009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resveratrol and Pterostilbene Inhibit SARS-CoV-2 Replication in Air-Liquid Interface Cultured Human Primary Bronchial Epithelial Cells.
    Ter Ellen BM; Dinesh Kumar N; Bouma EM; Troost B; van de Pol DPI; van der Ende-Metselaar HH; Apperloo L; van Gosliga D; van den Berge M; Nawijn MC; van der Voort PHJ; Moser J; Rodenhuis-Zybert IA; Smit JM
    Viruses; 2021 Jul; 13(7):. PubMed ID: 34372541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of simeprevir on the replication of SARS-CoV-2 in vitro and in transgenic hACE2 mice.
    Muturi E; Hong W; Li J; Yang W; He J; Wei H; Yang H
    Int J Antimicrob Agents; 2022 Jan; 59(1):106499. PubMed ID: 34929295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Virucidal and antiviral activity of astodrimer sodium against SARS-CoV-2 in vitro.
    Paull JRA; Heery GP; Bobardt MD; Castellarnau A; Luscombe CA; Fairley JK; Gallay PA
    Antiviral Res; 2021 Jul; 191():105089. PubMed ID: 34010661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cysteamine with In Vitro Antiviral Activity and Immunomodulatory Effects Has the Potential to Be a Repurposing Drug Candidate for COVID-19 Therapy.
    Alonzi T; Aiello A; Petrone L; Najafi Fard S; D'Eletto M; Falasca L; Nardacci R; Rossin F; Delogu G; Castilletti C; Capobianchi MR; Ippolito G; Piacentini M; Goletti D
    Cells; 2021 Dec; 11(1):. PubMed ID: 35011614
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suramin Inhibits SARS-CoV-2 Infection in Cell Culture by Interfering with Early Steps of the Replication Cycle.
    Salgado-Benvindo C; Thaler M; Tas A; Ogando NS; Bredenbeek PJ; Ninaber DK; Wang Y; Hiemstra PS; Snijder EJ; van Hemert MJ
    Antimicrob Agents Chemother; 2020 Jul; 64(8):. PubMed ID: 32513797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Moxidectin and Ivermectin Inhibit SARS-CoV-2 Replication in Vero E6 Cells but Not in Human Primary Bronchial Epithelial Cells.
    Dinesh Kumar N; Ter Ellen BM; Bouma EM; Troost B; van de Pol DPI; van der Ende-Metselaar HH; van Gosliga D; Apperloo L; Carpaij OA; van den Berge M; Nawijn MC; Stienstra Y; Rodenhuis-Zybert IA; Smit JM
    Antimicrob Agents Chemother; 2022 Jan; 66(1):e0154321. PubMed ID: 34633839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiviral Activity of the Propylamylatin
    Brown AN; Strobel G; Hanrahan KC; Sears J
    Viruses; 2021 Mar; 13(3):. PubMed ID: 33807769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AT-527, a Double Prodrug of a Guanosine Nucleotide Analog, Is a Potent Inhibitor of SARS-CoV-2
    Good SS; Westover J; Jung KH; Zhou XJ; Moussa A; La Colla P; Collu G; Canard B; Sommadossi JP
    Antimicrob Agents Chemother; 2021 Mar; 65(4):. PubMed ID: 33558299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro testing of combined hydroxychloroquine and azithromycin on SARS-CoV-2 shows synergistic effect.
    Andreani J; Le Bideau M; Duflot I; Jardot P; Rolland C; Boxberger M; Wurtz N; Rolain JM; Colson P; La Scola B; Raoult D
    Microb Pathog; 2020 Aug; 145():104228. PubMed ID: 32344177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiviral activities of mycophenolic acid and IMD-0354 against SARS-CoV-2.
    Kato F; Matsuyama S; Kawase M; Hishiki T; Katoh H; Takeda M
    Microbiol Immunol; 2020 Sep; 64(9):635-639. PubMed ID: 32579258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potential antiviral effects of pantethine against SARS-CoV-2.
    Abou-Hamdan M; Saleh R; Mani S; Dournaud P; Metifiot M; Blondot ML; Andreola ML; Abdel-Sater F; De Reggi M; Gressens P; Laforge M
    Sci Rep; 2023 Feb; 13(1):2237. PubMed ID: 36754974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antiviral properties of synthetic histidine derivatives containing membranotropic volumetrical carbocycles in their molecule against SARS-CoV-2 virus
    Garaev TM; Grebennikova TV; Avdeeva VV; Lebedeva VV; Larichev VF
    Vopr Virusol; 2023 Mar; 68(1):18-25. PubMed ID: 36961232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IFN-γ-mediated control of SARS-CoV-2 infection through nitric oxide.
    Silva BJA; Krogstad PA; Teles RMB; Andrade PR; Rajfer J; Ferrini MG; Yang OO; Bloom BR; Modlin RL
    Front Immunol; 2023; 14():1284148. PubMed ID: 38162653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metallodrug ranitidine bismuth citrate suppresses SARS-CoV-2 replication and relieves virus-associated pneumonia in Syrian hamsters.
    Yuan S; Wang R; Chan JF; Zhang AJ; Cheng T; Chik KK; Ye ZW; Wang S; Lee AC; Jin L; Li H; Jin DY; Yuen KY; Sun H
    Nat Microbiol; 2020 Nov; 5(11):1439-1448. PubMed ID: 33028965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro screening of a FDA approved chemical library reveals potential inhibitors of SARS-CoV-2 replication.
    Touret F; Gilles M; Barral K; Nougairède A; van Helden J; Decroly E; de Lamballerie X; Coutard B
    Sci Rep; 2020 Aug; 10(1):13093. PubMed ID: 32753646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitors of endosomal acidification suppress SARS-CoV-2 replication and relieve viral pneumonia in hACE2 transgenic mice.
    Shang C; Zhuang X; Zhang H; Li Y; Zhu Y; Lu J; Ge C; Cong J; Li T; Tian M; Jin N; Li X
    Virol J; 2021 Feb; 18(1):46. PubMed ID: 33639976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Probenecid inhibits SARS-CoV-2 replication in vivo and in vitro.
    Murray J; Hogan RJ; Martin DE; Blahunka K; Sancilio FD; Balyan R; Lovern M; Still R; Tripp RA
    Sci Rep; 2021 Sep; 11(1):18085. PubMed ID: 34508172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.